»
Advances in Cancer Research
 
 

Advances in Cancer Research, 1st Edition

 
Advances in Cancer Research, 1st Edition,Kenneth Tew,Paul Fisher,ISBN9780124071735
 
 
 

Advances in Cancer Research

Tew   &   Fisher   

Academic Press

9780124071735

9780124072039

416

229 X 152

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics.

Print Book + eBook

USD 205.20
USD 342.00

Buy both together and save 40%

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 171.00

eBook
eBook Overview

VST format:

DRM Free included formats: EPub, Mobi, PDF

USD 171.00
Add to Cart
 
 

Key Features

  • Provides information on cancer research
  • Oustanding and original reviews
  • Suitable for researchers and students

Description

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics.

Readership

Researchers and students in the basic and clinical sciences of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.

Kenneth Tew

Professor & Chairman, Dept of Cell & Molecular Pharmacology John C. West Chair of Cancer Research, Medical University of South Carolina, USA The Tew laboratory maintains an interest in using redox pathways as a platform to develop therapeutic strategies through drug discovery/development and biomarker identification. We interrogate how reactive oxygen and nitrogen species (ROS/RNS) impact cancer cells and develop novel drugs that impact on glutathione based pathways. Our research efforts have been integral to studies that have identified glutathione S-transferases (GST) as important in drug resistance, catalytic detoxification and as arbiters of kinase-mediated cell signaling events. In addition, we have been instrumental in defining how GSTP contributes to the process by which cells respond to ROS by selective addition of glutathione to specific protein clusters, so called S-glutathionylation. Each of these research areas has had broad impact on a number of cancer disciplines. Moreover, we have also been seminally involved in the Phase I to III clinical testing of three oncology drugs, Telcyta, Telintra and NOV-002. Other ongoing translational efforts have produced two ongoing clinical trials to measure the effectiveness of serum S-glutathionylated serine proteinase inhibitors as possible biomarkers for exposure to hydrogen peroxide mouthwashes and radiation.

Affiliations and Expertise

Deptartment of Cell & Molecular Pharmacology, Medical University of South Carolina, USA

Advances in Cancer Research, 1st Edition

  1. Role of Oxidative Stress and Microenvironment in Breast Cancer Development and Progression
    Carola A. Neumann
  2. Bioengineering Strategies for Cancer Targeting
    Xuejun Wen
  3. Advances in Understanding the Coupling of DNA Base Modifying Base Enzymes to Processes Involving Base Excision Repair
    Michael D. Wyatt
  4. Autophagy: Cancer's Friend or Foe
    Paul B. Fisher

 

Quotes and reviews

Praise for the Serial:
"This classic and essential series presents critical overviews on select aspects of both cancer research and the basic underlying sciences."--AMERICAN SCIENTIST
"Excellent, highly informative, in-depth reviews...expertly written, up-to-date, and well-referenced."--JOURNAL OF MEDICINAL CHEMISTRY
"This is a series that has a long tradition of excellence in the field of cancer biology."--DOODY'S PUBLISHING REVIEW
 
 

Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ

Contact Us